Concord Drugs consolidated net profit rises 375.00% in the September 2025 quarter

Sales decline 16.83% to Rs 10.28 crore

Net profit of Concord Drugs rose 375.00% to Rs 0.19 crore in the quarter ended September 2025 as against Rs 0.04 crore during the previous quarter ended September 2024. Sales declined 16.83% to Rs 10.28 crore in the quarter ended September 2025 as against Rs 12.36 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	10.28	12.36	-17
OPM %	10.70	7.12	-
PBDT	0.61	0.41	49
PBT	0.27	0.07	286
NP	0.19	0.04	375

Powered by Capital Market - Live News